Dyfyniad APA

Ozeki, K., Tanida, S., Mizoshita, T., Tsukamoto, H., Ebi, M., Mori, Y., . . . Joh, T. (2012). Combination Therapy with Intensive Granulocyte and Monocyte Adsorptive Apheresis plus Adalimumab: Therapeutic Outcomes in 5 Cases with Refractory Crohn's Disease. S. Karger AG.

Dyfyniad Arddull Chicago

Ozeki, Keiji, Satoshi Tanida, Tsutomu Mizoshita, Hironobu Tsukamoto, Masahide Ebi, Yoshinori Mori, Hiromi Kataoka, Takeshi Kamiya, and Takashi Joh. Combination Therapy With Intensive Granulocyte and Monocyte Adsorptive Apheresis Plus Adalimumab: Therapeutic Outcomes in 5 Cases With Refractory Crohn's Disease. S. Karger AG, 2012.

Dyfyniad MLA

Ozeki, Keiji, et al. Combination Therapy With Intensive Granulocyte and Monocyte Adsorptive Apheresis Plus Adalimumab: Therapeutic Outcomes in 5 Cases With Refractory Crohn's Disease. S. Karger AG, 2012.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.